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Purpose: This study investigated the influence of integrin expression as well as the oligosaccharide structure of surface
N-glycoproteins on cell behavior of two primary uveal (92–1 and Mel202) and two primary cutaneous (FM55P and
IGR-39) melanoma cell lines.
Methods: Cell adhesion to fibronectin and cell migration on fibronectin (wound healing) were selected as the studied cell
behavior parameters. The percentage of cells positive for expression of selected integrins was estimated by flow cytometric
analysis.  The  influence  of  β1–6  branched  complex-type  N-oligosaccharides  on  wound  healing  on  fibronectin  was
investigated. Cell surface β1–6 branched N-oligosaccharides were measured by their specific binding to PHA-L followed
by flow cytometry, and the fibronectin receptors bearing β1–6 GlcNAc branched N-linked glycans were identified. In
addition, the transcript of GnT-V (the enzyme that catalyzes the addition of N-acetylglucosamine to the core mannose of
di- and tri-antennary N-glycans through a β1–6 linkage) was analyzed by semiquantitative RT–PCR.
Results: Unlike the two examined cutaneous melanoma cell lines, neither of the uveal melanoma cells adhered to
fibronectin. The adhesion efficiency of IGR-39 cells was twice that of FM55P cells. In contrast, uveal melanoma cells
repaired scratch wounds on fibronectin-coated surfaces twice as fast as cutaneous melanoma cells did. The expression of
α3β1, α4β1, α5β1, and αvβ3 integrins, acting as fibronectin receptors, differed between the tested cell lines, and no distinct
pattern distinguished uveal melanoma from cutaneous melanoma except for high expression of α4β1 integrin on both
FM55P and IGR-39 cells. The results also demonstrated that the high levels of α3β1, α4β1, and α5β1 integrin expression on
IGR-39 cells promoted their strong attachment to fibronectin-coated surfaces. In addition, 92–1, Mel202, and FM55P
cells showed no or low adhesion to fibronectin, perhaps the result of low expression of fibronectin receptors excluding
high expression of α4β1 integrin in FM55P cells. Cell migration was significantly decreased in three out of four PHA-L-
treated cell lines, suggesting that β1–6 branched complex type N-oligosaccharides are critical for 92–1, Mel202, and
FM55P cell motility. Semiquantitative RT–PCR analysis showed that the tested cells did not differ in mRNA levels of
β1–6  –N-acetylglucosaminyltransferase  V.  However,  FACS  analysis  showed  that  92–1,  Mel202  and  IGR-39  cells
expressed significantly higher amounts of β1–6 branched N-oligosaccharides on the cell surface than FM55P cells did.
All examined α3, α5, αv, and β1 integrin subunits were shown to bear β1–6 branched N-linked glycans.
Conclusions: The role of integrins and their N-glycosylation in the regulation of uveal melanoma growth and progression
is largely unknown. These results reveal that cell surface complex-type N-glycans with GlcNAc β1–6 branches are
important factors determining the migration of primary uveal melanoma cells on fibronectin.
Uveal  melanoma  (UM)  is  the  most  common  primary
intraocular tumor in the adult population. Although significant
advances have been made in the ability to diagnose and treat
primary  tumors  of  UM,  the  mortality  rates  for  UM  have
changed little during the past few decades [1,2]. Because
metastatic disease can appear as late as 12 to 15 years after
enucleation of the ocular melanoma [3], the disease is likely
to have already disseminated at the time of diagnosis [4],
either  as  circulating  malignant  cells  or  as  occult
micrometastatic lesions [5]. UMs metastasize preferentially
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to the liver, and the average survival period for UM is less
than one year after clinical diagnosis of the lesions [2,5,6].
Little  is  known  about  the  molecular  mechanisms
underlying the metastatic potential of UM. Although UMs and
cutaneous  melanomas  (CM)  are  of  similar  embryological
origin and as such share several common features including
morphology and the properties of the melanogenesis pathway,
they  differ  significantly  in  their  epidemiological  [7],
cytogenetic [8,9], and immunological [10-12] characteristics
as well as biologic behavior [13,14]. UMs almost exclusively
metastasizes through the blood and preferentially to the liver,
whereas  CMs  are  capable  of  both  lymphatic  and
hematogenous (often less organ-specific) spread to almost any
organ in the body. Early events in the formation of metastases
include the escape of tumor cells from the primary tumor site
followed by invasion into the surrounding stroma [15]; these
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625events  depend  on  the  interaction  of  tumor  cells  with  the
extracellular matrix (ECM). Recently we showed that primary
UMs and primary CMs also differ in their adhesion to selected
components of the ECM, including fibronectin (FN), laminin,
and type IV collagen [16].
Successful metastasis requires an ordered series of steps,
including  detachment  of  tumor  cells  from  the  primary
neoplasm, invasion into and migration through ECM, entry
into  blood  as  well  as  lymph  vessels,  transport  along  the
circulatory  system,  adhesion  to  the  endothelium,
extravasation,  and  outgrowth  in  a  distant  organ  [17,18].
Receptors that mediate cell-cell and cell-ECM adhesion have
been shown to be key components in the metastatic cascade
[19]. It is reported that during the progression of malignant
CM, the expression profiles of several adhesion molecules
undergo changes which are directly or inversely correlated
with its metastatic potential [20-22]. Loss, overexpression or
malfunctioning of adhesion molecules may contribute to the
detachment  of  tumor  cells  from  the  primary  tumor,  local
invasion and metastasis [23].
The aims of this study were (1) to compare two human
primary  UM  cell  lines  (92–1,  Mel202)  and  two  human
primary CM cell lines (FM55P, IGR-39) in terms of their
adhesion  and  migration  (wound  healing)  to  FN;  (2)  to
determine the repertoire of integrins acting as FN receptors on
these melanoma cells; (3) to test whether the oligosaccharides
of surface N-glycoproteins influence melanoma cell behavior;
(4) to measure the surface expression of β1–6 branched N-
oligosaccharides on melanoma cells; and (5) to identify the
FN receptors bearing β1–6 branched N-oligosaccharides.
METHODS
Chemicals: Phaseolus vulgaris agglutinin (PHA-L), PHA-L
immobilized on cross-linked 4% agarose, proteinase inhibitor
cocktail, protamine sulfate, penicillin-streptomycin solution,
Tween 20, bovine serum albumin (BSA), and poly-L-lysine
were obtained from Sigma-Aldrich (St. Louis, MO). Fetal
bovine serum (FBS) was from GibcoBRLTM (Paisley, UK).
The  polyvinylidene  difluoride  (PVDF)  membranes  were
products of Millipore (Bedford, MA, USA). We purchased 4-
nitroblue-tetrazolium  salt  and  5-bromo-4-chloro-3-
indolylphosphate solution from Roche Diagnostics GmbH
(Mannheim,  Germany)  and  obtained  96-well  and  24-well
plates coated with FN from BD Biosciences (San Diego, CA).
Antibodies used in flow cytometric analysis as well as for
immunodetection  are  listed  in  Table  1  and  Table  2,
respectively.  All  remaining  chemicals  were  of  analytical
grade, commercially available.
Cell lines and culture condition: Included in the study were
four cell lines received from the ESTDAB Melanoma Cell
Bank (Tűbingen, Germany). Two cell lines were derived from
a primary UM (92–1 [24] and Mel202 [11]) and two others
were derived from a primary CM (FM55P [25] and IGR-39
[26]).
All  cell  lines  were  cultured  in  RPMI-1640  medium
(GibcoBRLTM),  supplemented  with  10%  heat-inactivated
FBS,  and  penicillin-streptomycin  solution.  Cells  were  fed
biweekly and grown to confluence as a monolayer in 5%
CO2-enriched atmosphere at 37 °C in a humidified incubator,
and passaged by treatment with 0.05% trypsin-EDTA solution
(Sigma-Aldrich). Experiments were initiated when cells had
reached subconfluence.
Adhesion assay: Melanoma cell adhesion to FN was assessed
according  to  the  protocol  previously  described  [16].  The
reference value for 100% attachment was estimated from cells
in wells coated with 500 μg/ml poly-L-lysine. All data are
given  as  relative  percentages  of  adhesion  compared  to
adhesion  on  poly-L-lysine  (taken  as  100%).  Values  are
expressed as mean ± standard deviation of three separate
experiments.
Wound healing assay: Cells were grown on FN to confluence.
Then the medium was aspirated, and the cell-coated surface
was scraped with a 200 μl pipette tip in a single stripe. The
scrape-wounded surface was washed once with PBS and twice
with  RPMI-1640  supplemented  with  FBS,  and  then  the
wounds in the cultures were allowed to heal for 24 h at 37 °C.
In  some  experiments,  wound  healing  in  culture  medium
containing 25 μg/ml PHA-L was examined. The applied dose
of PHA-L had no effect on the viability or growth rate of the
tested cells as demonstrated by trypan blue exclusion and
3[4,5-dimethyldiazol-2-yl]-2,5diphenyltetrazolium  bromide
(MTT) tests (data not shown). Migration of cells into wounded
areas  was  observed  with  an  inverted  microscope  and
photographed.  The  average  extent  of  wound  closure  was
quantified  by  multiple  measurements  of  the  width  of  the
wound space for each of these cases. Twenty measurements
of two separate trials were made and averaged for all these
conditions. Values are expressed as mean ± standard deviation
of three separate experiments.
Flow  cytometric  analysis:  Expression  of  human  integrin
subunits  was  assessed  by  flow  cytometry  as  previously
described [27]. Briefly, cells (1 × 105) were incubated for 45
TABLE 1. RANGE, SPECIFICITY, AND SUPPLIER OF MONOCLONAL ANTIBODIES USED FOR FLOW
CYTOMETRY EXPERIMENTS.
Immunogen Antibody Manufacturer
α3
M0608
(monoclonal – clone P1B5)
DAKO
α4
MAB16983
(monoclonal – clone P1H4)
Chemicon
α5
CBL497
(monoclonal – clone SAM-1)
Chemicon
αv
MAB1976
(monoclonal – clone LM609)
Chemicon
rabbit anti-mouse
F(ab')2
F313
(FITC–conjugated)
DAKO
mouse IgG1
X0931
(monoclonal – clone DAK-
GO1)
DAKO
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626min on ice with antibodies against 50 μl/ml α3, 50 μl/ml α4,
75 μl/ml α5, integrin subunits as well as against 10 μl/ml
αvβ3, integrin, or 50 μl/ml normal mouse IgG as negative
control, Cells were then washed in phosphate-buffered saline
(PBS, pH 7.2) and then incubated with 50 μl/ml fluorescein
isothiocyanate  (FITC)-conjugated  antimouse  IgG  (Fab’)2
fragments for 45 min on ice. PHA-L binding to cells was
performed  according  to  the  method  of  Chakraborty  et  al.
[28]. Briefly, cells (1 × 105) were incubated with 10 μg/ml
FITC-conjugated PHA-L (Vector, Burlingame, CA) in PBS
containing 2% BSA, for 45 min on ice. The cells were then
washed  in  PBS,  and  assessed  for  fluorescence  in  a
FACSCalibur flow cytometer (BD Biosciences, San Diego,
CA).  A  total  of  104  cells  were  analyzed  for  each
immunofluorescence  profile.  Antibodies  used  in  flow
cytometric analysis are listed in Table 1.
Expression  of  mRNA  for  β1,6-N-
acetylglucosaminyltransferase V: RNA was extracted using
RNeasy  Mini  Kit  (Qiagen,  Hilden,  Germany).  The
concentration and quality of RNA samples were measured
with a Spectrophotometer UV/VIS (Beckman) Then 1 μg of
total  cellular  RNA  was  reverse  transcribed  by  reverse
transcriptase Omniscript (Qiagen) with oligo dT23 according
to manufacture protocol. PCR amplification of the sample was
performed with both specific primer pairs for each of the
studied  glycosyltransferases:  β1–6-N-
acetylglucosaminyltransferase  V  –  MGAT-5,  and  human
glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)
genes. The PCR reaction comprised 30 cycles and consisted
of denaturing at 94 °C (1 min), annealing at 60.5 °C (1 min),
and extension at 72 °C (2 min). The PCR mixture contained:
2.5 μl 10x PCR buffer, 5 μl Q-solution, 1 μl MgCl2, 2 μl sample
cDNA, 1.6 μl 10 mM dNTPs, 0.25 μl Taq DNA polymerase
(Qiagen), 1 μl of each glycosyltransferase specific primer
(concentration 10 μM), and water in a final volume of 22 μl.
The negative control reaction was performed simultaneously.
Reaction  products  obtained  after  30  cycles  were
electrophoresed on 2% agarose containing ethidium bromide.
Glycosyltransferase mRNA expression of each sample was
determined in at least two independent experiments (separate
RNA  isolation)  and  was  normalized  relative  to  GAPDH
values.  Sequences  of  forward  (F)  and  reverse  (R)
oligonucleotide primers for MGAT-5 gene and length of the
amplification products were as follows: F: 5′-GTG GAT AGC
TTC TGG AAG AA-3′ R: 5′-CAG TCT TTG CAG AGA
GCC-3′ (856 bp).
Precipitation with Phaseolus vulgaris agglutinin lectin: After
reaching early confluency, cells were washed twice with PBS,
harvested  with  a  rubber  policeman  and  pelleted  by
centrifugation. Then the cells were homogenized on ice in
10 mM Tris/HCl, pH 7.5, containing 1 mM EDTA and a
TABLE 2. RANGE, SPECIFICITY, AND SUPPLIER OF MONOCLONAL AND POLYCLONAL
ANTIBODIES USED FOR IMMUNODETECTION OF INTEGRIN CHAINS IN MATERIAL
RECOVERED AFTER PRECIPITATION WITH PHASEOLUS VULGARIS AGGLUTININ BOUND TO
AGAROSE.
Immunogen Antibody Manufacturer
α3 AB1920 Chemicon
α5 AB1928 Chemicon
αv AB1930 Chemicon
β1
MAB2251
(monoclonal – clone
B3B11)
Chemicon
anti-rabbit IgG AP322A
(AP–conjugated) Chemicon
anti-mouse IgG A1682
(AP-conjugated) Sigma
Figure  1.  Adhesion  of  uveal  (92–1,
Mel202)  and  cutaneous  melanoma
(FM55P, IGR-39) cells to fibronectin.
Each  result  is  the  average  of  three
independent  experiments  done  in
triplicate.  All  data  are  given  as
percentage  of  adhesion  relative  to
adhesion  on  poly-L-lysine  (taken  as
100%).  Error  bars  indicate  standard
deviations.  Asterisk  (*)  indicates
p<0.05.
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627proteinase inhibitor cocktail, followed by incubation with the
same buffer containing additionally 1% Triton X-100 and
0.3% protamine sulfate for 1 h on ice. Finally, cell extracts
were clarified by centrifugation at 16000 g for one hour.
Precipitation with the use of immobilized PHA-L lectin
was performed according to the modified method of Seales et
al. [29]. Briefly, 1 mg cell extracts were incubated overnight
at 4 °C with 50 μl of PHA-L immobilized on cross-linked 4%
beaded  agarose,  3  mg  lectin/ml  packed  gel.  PHA-L/
glycoprotein complexes collected by brief centrifugation were
then  washed  three  times  with  10  mM  HEPES,  pH  7.5,
containing 150 mM NaCl, followed by one wash with PBS.
Glycoproteins were released from the complexes by boiling
in electrophoresis sample buffer before being subjected to
Figure 2. Effect of phaseolus vulgaris
agglutinin  on  repair  of  wounds  in
monolayers of 92–1, Mel202, FM55P,
and IGR-39 cells. A line was scratched
with  a  plastic  pipette  tip  through  the
confluent monolayer of cells maintained
in serum-containing RPMI 1640 on a
fibronectin-coated  surface.  The
wounded cultures were allowed to heal
for 24 h at 37 °C in the presence or
absence of 25 μg/ml phaseolus vulgaris
agglutinin  (PHA-L)  in  serum-
containing RPMI 1640. A: Panels show
migration  of  cells  in  the  presence  or
absence of PHAL after 24 h. B: The
extent of wound closure was quantified
by measurements of the width of the
wound  space  for  each  case.  For  this
value, the width was measured at twenty
different locations in the wound and the
mean value was compared to the width
of the original closure (0 h). Values are
means  ±  standard  deviation  of  three
separate  experiments.  Asterisk  (*)
indicates p<0.05.
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628SDS–PAGE. Plain agarose was used as negative control (data
not shown).
SDS–PAGE and western blotting: For electrophoresis, equal
volumes of proteins (1/20 of precipitated materials) mixed
with sample buffer and heated, were separated on 10% SDS-
polyacrylamide gels under nonreducing condition according
to the method of Laemmli [30]. Following separation, the
proteins were transferred onto PVDF membranes in buffer
consisting  of  25  mM  Tris,  0.192  M  glycine,  and  20%
methanol, pH 8.4, overnight at constant amperage 0.1 A with
cooling (Bio-Rad). Polyacrylamide gels were calibrated for
molecular weight determination using the Sigma Standard Kit
for electrophoresis in SDS (205–29 kDa).
Identification of the proteins bearing β1–6 GlcNAc branched
N-linked oligosaccharides: Materials precipitated with PHA-
L  lectin  were  separated  by  SDS–PAGE  and  blotted  onto
PVDF membrane. Next the blots were blocked with 1% BSA
in 20 mM Tris/HCl, pH 7.6, containing 0.15 M NaCl and 0.1%
Tween 20 (TBS/Tween). Afterwards, the membranes were
incubated for 2 h in 1% BSA in TBS/Tween containing a
1:1000 dilution of one of the following antibodies specific for
different integrin subunits: α3, α5, αv, and β1. Following a triple
wash with TBS/Tween, the membranes were incubated for 1
h with the secondary antibodies either alkaline phosphatase
conjugated  goat  anti-rabbit  IgG  (for  α3,  α5,  αv,  integrin
subunits; 1:250 dilution in TBS/Tween with 1% BSA) or
alkaline phosphatase coupled goat anti-mouse IgG (for β1
integrin subunit; 1:500 dilution in TBS/Tween with 1% BSA).
Visualization of immunoreactive proteins was achieved with
the use of 4-nitroblue-tetrazolium salt/5-bromo-4-chloro-3-
indolylophosphate  solution.  Antibodies  used  for
immunodetection are listed in Table 2.
Statistics: Statistical analysis was performed with the use of
Dunkan’s new multiple range test. A p value less than 0.05
was considered statistically significant.
Figure  3.  Expression  of  integrins  on
human  uveal  (92–1,  Mel202)  and
cutaneous melanoma (FM55P, IGR-39)
cells. Melanoma cells were examined by
flow  cytometry  for  the  expression  of
α3β1, α4β1, α5β1, and αvβ3 integrins, and
data were compared to cells incubated
with  normal  mouse  IgG.  Fluorescein
isothiocyanate  (FITC)-conjugated
rabbit anti-mouse IgG (Fab’)2 fragments
were used for detection. Fluorescence
signals of 10,000 cells were counted for
each integrin subunit tested. Histograms
of  cells  versus  log  fluorescence  were
generated.  A:  Panels  show  FACS
profile for integrin-positive cell lines.
Colored areas indicate the fluorescence
profile  of  cells  after  indirect
fluorescence staining with anti-integrin
monoclonal  antibodies.  Open
histograms  represent  background
fluorescence.  Relative  fluorescence  is
shown as a logarithmic scale of 4 log
cycles on the x-axis, and cell number as
a linear scale on the y-axis. Data from
one  of  three  similar  experiments  are
presented. The negative control for each
line  is  different  in  some  experiments
because the experiments were not run on
the same occasion. B: Diagram shows
percentage  of  melanoma  cells
expressing  α3β1,  α4β1,  α5β1,  and  αvβ3
integrins.  C:  Diagram  shows
quantitation  of  data  from  flow
cytometric analyses. Values are means
± standard deviation of three separate
experiments.  Asterisk  (*)  indicates
p<0.05.
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629Other  methods:  Protein  concentrations  were  measured
according to Peterson [31] with BSA as standard.
RESULTS
Cell-FN  interaction,  mediated  through  several  different
receptors,  has  been  implicated  in  a  wide  variety  of  cell
activities, including important roles at several stages of tumor
development [32]. In the first part of this study we compared
primary UM and primary CM in terms of their adhesion and
migration to FN. UM cells did not adhere to FN. As shown in
Figure 1, the two examined CM cell lines attached to FN, but
the adhesion efficiency of IGR-39 cells (80%) was twice that
of  FM55P  cells  (40%).  Interestingly,  UM  cells  repaired
scratch wounds twice as fast as CM cells did (36% and 18%
wound closure after 24 h, respectively; Figure 2).
Among the various classes of cell adhesion molecules,
integrins  are  particularly  associated  with  cell  adhesion  to
extracellular  matrices,  and  altered  levels  of  integrin
expression are related to tissue invasion and metastasis in
many types of cancer. In the second part of this study we used
flow cytometry to characterize UM and CM cells with respect
to  their  cell  surface  integrins  acting  as  receptors  for  FN
(α3β1,  α4β1,  α5β1,  αvβ3),  applying  specific  monoclonal
antibodies that recognize different integrin heterodimers or
integrin  subunits  (Table  1).  The  flow  cytometry  data  are
summarized  in  Figure  3.  FN  receptor  expression  differed
between  the  tested  cell  lines,  but  no  distinct  pattern
distinguished UM from CM except for high expression of
α4β1 integrin on both FM55P and IGR-39 cells. The results
also showed that the high levels of α3β1, α4β1 and α5β1 integrin
expression on IGR-39 cells correlate with strong attachment
to FN-coated surfaces, and the high expression of α4β1 integrin
on FM55P probably was enough to make them adhere weakly
to FN. Interestingly, the expression of α5β1 integrin, which is
known to be a major FN receptor, was low on 92–1 (16%),
Mel202 (29%), and FM55P (22%) cells.
Most integrins are able to bind different ligands with
different  affinities.  The  affinity  of  integrins  may  vary
depending on the cell type in which they are expressed or as
the result of conformational changes. Although the molecular
basis  of  adhesion  molecule-ligand  interaction  is  not  fully
understood,  integrin  glycosylation  represents  a  kind  of
regulation by which a wide variety of these receptors have
their specificity and affinity modulated in several cell lines
[33-38]. Because one of the common structural alterations in
cell surface glycans observed in various human and rodent
tumors  is  highly  elevated  expression  of  β1–6-N-
acetylglucosamine  (β1–6  GlcNAc)  branched  tri-  and
tetraantennary complex type N-glycans [39], we also tested
their influence on melanoma cell migration. Addition of PHA-
Figure 4. Flow cytometric analysis of
phaseolus  vulgaris  agglutinin  binding
on the surface of human uveal (92–1,
Mel202)  and  cutaneous  melanoma
(FM55P, IGR-39) cells. A: Histogram
of fluorescence intensity with or without
fluorescein  isothiocyanate  (FITC)-
conjugated  phaseolus  vulgaris
agglutinin.  B:  Quantification  of  data
from  flow  cytometric  analyses.
Fluorescence  intensity  relative  to
negative  control,  representing  means
from three pooled experiments. Asterisk
(*) indicates p<0.05.
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630L,  whose  preferred  ligands  are  β1–6  branched  N-glycans
[40],  reduced  the  rate  of  92–1,  Mel202,  and  FM55P  cell
migration into scratch wounds on FN-coated wells by 79%,
93%, and 63%, respectively, indicating the participation of
β1–6 branched N-oligosaccharides in this process, but it had
no effect on the migration rate of IGR-39 cells (Figure 2).
The  formation  of  β1–6  branches  on  the  trimannosyl
terminus of N-linked oligosaccharides is controlled via the
activity of GnT-V, the enzyme that catalyzes the addition of
N-acetylglucosamine  to  the  core  mannose  of  di-  and
triantennary N-glycans through a β1–6 linkage [41]. Analysis
of  the  transcript  of  GnT-V  by  semiquantitative  RT–PCR
showed that the tested cells did not differ in their mRNA levels
of GnT-V (data not shown). To assess GnT-V activity in vivo,
we measured cell surface β1–6 branched N-oligosaccharides
via their specific binding to PHA-L and detection by flow
cytometry. It showed that 92–1, Mel202, and IGR-39 cells
expressed significantly higher amounts of β1–6 branched N-
oligosaccharides on the cell surface than FM55P cells did, as
reflected  in  the  mean  fluorescence  intensity  of  the  cells
(Figure  4):  the  former  cells  showed  mean  fluorescence
intensity twice that of FM55P cells. Presumably the enhanced
PHA-L binding was restricted to the cell surface, because the
binding and wash procedures were performed on ice with no
previous lysis of cells.
To  identify  the  glycoproteins  bearing  β1–6  GlcNAc
branched  N-glycans  from  four  melanoma  cell  lines,  we
precipitated clarified lysates of 92–1, Mel202, FM55P, and
IGR-39 with PHA-L lectin. The glycoproteins recovered after
precipitation  were  electrophoresed  under  nonreducing
conditions, blotted onto a PVDF membrane, and probed with
antibodies specific for different integrin subunits: α3, α5, αv,
and β1. Immunodetection clearly indicated the presence of β1–
6  GlcNAc  branched  N-glycans  on  these  integrin  chains
(Figure 5).
DISCUSSION
Many studies have shown tumor cells to be generally less
adhesive  and  to  deposit  less  ECM  than  their  normal
counterparts. The loosened matrix adhesion of tumor cells
may permit them to leave their original site in the tissue.
Previously we demonstrated that although both CM and UM
are  similarly  derived  from  neuroectodermal  tissues,  they
differ in their adhesion to type IV collagen, laminin and FN
[16]. To study the biologic mechanisms that underlie this
distinctive biologic behavior, we investigated the influence of
the surface expression of the integrins that act as FN receptors,
Figure  5.  Immunodetection  of  α3,  α5,
αv, and β1 in materials obtained after
precipitation of 92–1, Mel202, FM55P,
and IGR-39 cell extracts with phaseolus
vulgaris  agglutinin  bound  to  agarose.
One  mg  of  the  cell  extracts  were
incubated  overnight  with  phaseolus
vulgaris  agglutinin  (PHA-L)
immobilized on cross-linked 4% beaded
agarose.  Glycoproteins  were  released
from  the  complexes  by  boiling  in
electrophoresis  sample  buffer  before
being  subjected  to  10%  SDS–PAGE.
Following separation, the proteins were
blotted  onto  PVDF  membrane.  After
being blocked the blots were incubated
with  one  of  the  following  antibodies
specific for different integrin subunits:
α3, α5, αv, and β1. Next, the membranes
were  incubated  with  the  secondary
antibodies  either  alkaline  phosphatase
conjugated goat anti-rabbit IgG (for α3,
α5,  αv,  integrin  subunits)  or  alkaline
phosphatase  coupled  goat  anti-mouse
IgG  (for  β1  integrin  subunit).
Visualization  of  immunoreactive
proteins was achieved with the use of 4-
nitroblue-tetrazolium  salt/5-bromo-4-
chloro-3-indolylophosphate  solution.
Lane  S  shows  position  of  molecular
weight markers.
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631as  well  as  the  expression  of  β1–6  branched  N-linked
oligosaccharides on surface proteins, on UM (92–1, Mel202)
and CM (FM55P, IGR-39) cell behavior. In this study we
showed that the UM cells did not adhere to FN and that they
repaired wounds twice as fast as CM cells did.
It is well documented in the literature that the expression
pattern of adhesive molecules differs widely between normal
and malignant tissues. The gain or loss of adhesive molecule
expression on cancer cells appears to be a natural consequence
of their adaptation and survival in a different environment.
Integrins, which are the major class of adhesion molecules
responsible for mediating cellular interaction with the ECM,
seem to have an important role in various aspects of cancer
development. Several studies have focused on the integrin
expression of melanoma cells, but only the expression of
α2β1, α3β1, α6β1 and αvβ3 integrins was found to be associated
with  tumor  progression  in  CMs  [42-45].  No  correlation
between  integrin  expression  and  cell  type  or  aggressive
behavior has been has been confirmed in UM [46,47]. The
present  study  found  no  distinct  pattern  of  FN  receptor
expression among primary UMs and CMs, except for high
expression of α4β1 integrin on both FM55P and IGR-39 cells.
Contrasting with our results showing a high level of α4β1
integrin on CM cells are previous findings that α4β1 integrin
expression was rare in CM [46]. The divergent outcomes may
be attributable to differences in the techniques and antibodies
used.  The  high  levels  of  α3β1,  α4β1,  and  α5β1  integrin
expression on IGR-39 cells seemed to be associated with their
strong  adhesion  to  FN.  Interestingly,  92–1,  Mel202,  and
FM55P cells showed no or weak adhesion to FN, perhaps the
result of low expression of FN receptors except for that of
α4β1 integrin on FM55P cells. The high expression of α4β1
integrin on FM55P cells probably was enough to make them
adhere weakly to FN. These results were further confirmed by
assays of adhesion inhibition in the presence of specific anti-
integrin monoclonal antibodies (data not shown).
There is increasing evidence that progression of cancer
from  a  tumorigenic  to  metastatic  phenotype  is  directly
associated  with  an  increased  level  of  β1–6  branched  N-
oligosaccharides  as  the  result  of  hyperactivity  of  GnT-V
[41,48]. Perhaps the most interesting findings of this study are
those related to the involvement of β1–6 branched N-linked
oligosaccharides on surface glycoproteins in FM55P, 92–1
and Mel202 cell migration. Although literature data, including
results obtained in our laboratory, describe the involvement
of  β1–6  branched  N-glycans  in  CM  cell  adhesion  and
migration [49,50], the present study is the first to present data
with respect to UM. The functional significance of increased
β1–6  branching  in  N-glycoproteins  has  not  been  well
established, but it has been associated with several hallmarks
of tumor progression: decreased substrate adhesion, loss of
contact inhibition, increased migration in vitro, and increased
metastasis in vivo [28,37,41,48]. We recently showed that
changes in the number of proteins acting as substrates for
GnT-V were associated more with melanoma development
and  progression  than  with  expression  of  cell  adhesion
molecules [50]. It is believed that expression of β1–6 branched
N-oligosaccharides on integrins and other adhesion receptors
may facilitate the turnover of cell-cell and cell-ECM contacts
to enhance cell motility [41,51].
Here  we  provided  evidence  that  β1–6  branched  N-
oligosaccharides on the cell surface of 92–1, Mel202, and
FM55P cells facilitated their migration on FN. How is the
effect  of  the  sugar  moieties  achieved?  Cell  migration  is
influenced  by  the  strength  of  transient  cell-substratum
attachment and depends on ligand and integrin levels, as well
as integrin-ligand binding affinities [52]. Cell migration is
most rapid at an intermediate ratio of cell-substratum adhesion
to contractile force; then the cell can still extend lamellae and
form  new  attachments  at  the  cell  front  but  break  the
attachment at the rear. In 92–1, Mel202, and FM55P cells,
altered surface glycosylation might induce functional changes
in adhesion proteins and in this way decrease the binding
capacity  of  integrins  to  FN,  possibly  by  holding  the
conformation in the low-affinity form to the ligand. Indeed,
studies  with  tri-  and  tetraantennary  minimal  energy
conformers indicate that the β1–6 branch is folded back to the
protein structure [48], and this in turn could likely modulate
the  integrin  conformation,  and  thus  also  integrin  function
(affinity).  It  has  also  been  shown  that  β1–6  branched  N-
glycans  may  reduce  the  stability  of  the  integrin  receptor
aggregates that maintain firm cell-substratum attachment, and
thereby facilitate cell motility [37,41]. From flow cytometric
studies it is known that 92–1 and Mel202 cells possess more
glycoproteins  bearing  β1–6  branched  N-oligosaccharides
than do FM55P cells, so it is not surprising that 92–1 and
Mel202 cells seemed more sensitive to PHA-L treatment as
judged by their 79% and 93% versus 63% decrease in wound
healing assays. Interestingly, IGR-39 cells, which possess an
amount  of  β1–6  branched  N-oligosaccharides  on  the  cell
surface similar to the level on UM cells, were not sensitive to
PHA-L treatment in the wound healing assay. Possibly the
high level of FN receptors on these cells had a stronger effect
on the degree of transient cell-substratum attachment than did
modulation  of  integrin-FN  binding  by  β1–6  branched  N-
oligosaccharides. This suggestion needs to be confirmed.
Malignant  cells  acquire  invasive  potential  by
accumulating  features  including  increased  cell  motility,
secretion  of  proteolytic  enzymes,  and  alteration  of  cell-
substratum  and  cell-cell  adhesion  [53,54].  Tumor  cell
adhesion is a fundamental event in the formation of distant
tumor  metastases;  during  the  formation  of  metastases,
malignant cells often show decreased cell-cell and cell-ECM
interaction at the primary tumor site and must establish new
adhesive interactions at secondary sites. Elevated expression
of PHA-L reactive oligosaccharides in carcinomas is usually
associated with tumor progression and metastasis, as has been
shown in breast and colon cancers [55,56] or melanoma [28,
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63250].  Inhibition  of  the  expression  of  β1–6  branched  N-
oligosaccharides through different strategies always results in
the loss of metastatic ability. As 92–1 and Mel202 cells did
not adhere to FN and were twice as mobile as CM cells, and
since the presence of β1–6 branched N-oligosaccharides on
their  surface  enhanced  their  motility,  it  is  tempting  to
speculate that these cells may have also been more metastatic,
but this requires confirmation.
One aspect of metastasis that has intrigued scientists for
over a century is organ-specific metastasis. As mentioned, the
metastatic behavior of UMs and CMs in the body differs
greatly. It is believed that molecules on the surface of tumor
cells  are  the  principal  regulators  of  adhesion  to  organ
components. Indeed, most of the cell lines expressing β1–6
branched N-oligosaccharides have been shown to metastasize
to either the liver or the lungs [41,57,58]. β1–6 branched N-
oligosaccharides possibly influence adhesion by providing
specific  ligands  to  the  lectin  receptors  on  the  target  site,
because the terminal substitution on these glycans influences
the choice of metastatic site [59-62]. It has been demonstrated
that  β1–6  branched  N-oligosaccharides  substituted  with
polylacNAc possibly metastasize to the lungs, while cells
expressing unsubstituted multiantennary N-oligosaccharides
home in the liver which express galectin-1 [61,62]. UM cells
metastasize specifically to the liver, so it would be useful to
find clear evidence for the role of galectin-1 in liver-specific
metastasis.
In 92–1, Mel202, and IGR-39 cells the levels of cell
surface β1–6 branched N-oligosaccharides were significantly
higher than in FM55P cells, but it did not appear to have
resulted from differences in the mRNA expression of GnT-V
in  these  cells  as  shown  by  semiquantitative  RT–PCR.
Nevertheless, it should be stressed that GnT-V activity may
undergo regulation not only at expression level. Although
little  is  known  about  the  cellular  regulators  of  GlcNAc
transferases, there are few reports describing decrease in GnT-
V activity in response to the metastasis gene nm23-H1 and the
tumor supressor gene p16 [63], and loss of β1–6 GlcNAc
branching of β1 integrins and concurrent dramatic reduction
in migration through ECM after overexpression of 16-kDa
membrane subunit of vacuolar H+-ATP-ase [64]. Moreover,
it has been shown that the basal activity of GnT-V is also
regulated  by  Ras/Raf-1/MEK/MAPK  cascade  and
phosphatidylinositol-3-kinase/protein  kinase  B  signaling
pathway [65] and changes also during the cell cycle [66]. In
addition,  β1–6  branching  is  also  dependent  upon  GnT-V
having  access  to  suitable  oligosaccharide  acceptors  [67].
GnT-V  competes  for  the  same  substrate  as  N-
acetylglucosaminyltransferase III (GnT-III) [66]. Substitution
by GnT-III effectively reduces β1–6 branching because GnT-
V cannot act on such bisected precursor, resulting in lowering
tumor  cell  metastasis  [51,68-70].  Although  it  is  well
documented in the literature that β1–6 branched N-glycans
contribute to cancer progression, the role of integrins with a
bisecting GlcNAc cannot be neglected. It has been shown that
the  modification  of  α5β1  integrin  by  bisecting  GlcNAc
inhibited cell spreading and migration on FN, subsequently
leading to the down-regulation of integrin-mediated signaling
[70,71].
The  present  studies  on  UM  cells  showed  remarkable
homogeneity  of  their  adhesion  and  migration  properties,
expression  of  FN  receptors,  level  of  β1–6  branched  N-
oligosaccharides on the cell surface, and the influence of these
glycans on cell migration. The roles of integrins and their N-
glycosylation in the regulation of UM growth and progression
are largely unknown. To our knowledge, this study is the first
to demonstrate the role of β1–6 branched N-oligosaccharides
on surface glycoproteins in the migration of UM cells. Further
studies  of  other  melanomas  are  needed  to  confirm  these
interesting findings.
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